| API | Produkt Namme | FASE NO. | Klassifikaasje |
| Ceritinib/Crizotinib | (R)-5-bromo-3-(1-(2,6-dichlor-3-fluorfenyl)ethoksy)pyridin-2-amine | 877399-00-3 | Anti-kanker |
| Alpelisib | 2-(1,1,1-trifluor-2-methylpropan-2-yl)-4H-pyran-4-on | 1357476-64-2 | Anti-kanker |
| Alpelisib | 2-(1,1,1-trifluor-2-methylpropan-2-yl)pyridin-4(1H)-on | 1357476-66-4 | Anti-kanker |
| Apalutami | 4-amino-2-fluor-N-methylbenzamide | 915087-25-1 | Anti-kanker |
| Apalutami | 5-Nitro-3-trifluoroMethylpyridine-2-karbonitril | 573762-57-9 | Anti-kanker |
| Apalutami | 4-amino-2-fluoro-N-methylbenzamide | 915087-25-1 | Anti-kanker |
| Apalutami | 5-Amino-3-(trifluormethyl)pyridine-2-karbonitril | 573762-62-6 | Anti-kanker |
| Cabozantinib | 4-Hydroxy-6,7-dimethoxyqunioline | 13425-93-9 | Anti-kanker |
| Cabozantinib | 1,1-Cyclopropanedicarboxylic acid | 598-10-7 | Anti-kanker |
| Cabozantinib | 1-(4-FLUOROFENYLCARBAMOYL)CYCLOPROPANECARBOKSYLISÊR | 849217-48-7 | Anti-kanker |
| Cabozantinib | 4-Chloor-6,7-dimethoxyquioline | 35654-56-9 | Anti-kanker |
| Carfilzomib | Methyl-3-formyl-2-nitrobenzoat | 138229-59-1 | Anti-kanker |
| Carfilzomib | (S)-4-(tert-butoksykarbonylamino)-2,6-dimethyl-1-hepten-3-on | 247068-81-1 | Anti-kanker |
| Fulvestrant | (7a,17b)-7-[9-[(4,4,5,5,5-pentafluorpentyl)sulfinyl]nonyl]estra-1,3,5(10)-triene-3,17-diol | 129453-61-8 | Anti-kanker |
| LOXO-292 | 4-(6-fluorpyridin-3-yl)-6-hydroxypyrazolo[1,5-a]pyridine-3-karbonitril | 2222654-09-1 | Anti-kanker |
| Methotrexate | 5-Nitroso-2,4,6-triaminopyrimidine | 1006-23-1 | Anti-kanker |
| Neratinib | trans-4-Dimethylaminocrotonic acid hydrochloride | 848133-35-7 | Anti-kanker |
| Neratinib | Methyl 2-oxoindole-6-carboxylate | 14192-26-8 | oaren |
| Neratinib | N-(4-aminofenyl)-N-methyl-2-(4-methylpiperazin-1-yl)acetamide | 262368-30-9 | oaren |
| Neratinib | Trimethyl ortobenzoat | 707-07-3 | oaren |
| Osimertinib | 4-fluor-2-methoxy-5-nitroaniline | 1075705-01-9 | Anti-kanker |
| Pirfenidone | 2-Amino-5-methylpyridine | 1603-41-4 | Anti-kanker |
| Lenvatinib | 4-chloro-7-Methoxyquinoline-6-carboxaMide | 417721-36-9 | Anti-kanker |
| Lenvatinib | 4-amino-3-chlorofenol | 17609-80-2 | Anti-kanker |
| Lenvatinib | 1-(2-chlor-4-hydroxyphenyl)-3-cyclopropylurea | 796848-79-8 | Anti-kanker |
| Lenvatinib | 4-Amino-3-chlorofenol hydrochloride | 52671-64-4 | Antibiotika |
| Meropenem | 4AA: 4-Acetoxy-2-azetidinone | 28562-53-0 | Antibiotika |
| Meropenem | MAP (Beta-methylvinylfosfaat) | 90776-59-3 | Antibiotika |
| Cefuroxime | Methoxyammoniumchloride | 593-56-6 | Antibiotika |
| Clotrimazole / Diclofenazole Econazole / Ketoconazole | Imidazole | 288-32-4 | Antibiotika |
| Doxycycline hyclate | DOXYCYCLINE HYDROCHLORIDE, VETRANAL | 24390-14-5 | Antibiotika |
| Posaconazole | (5R-cis)-Tolueen-4-sulfonzuur 5-(2,4-difluorfenyl)-5-(1H-1,2,4-triazol-1-yl)methyltetrahydrofuran-3-ylmethylester | 149809-43-8 | Antibiotika |
| Posaconazole | 2-[(1S,2S)-1-etyl-2-besyloksypropyl]-2,4-dihydro-4-[4-[4-(4-hydroxyfenyl)-1-piperazinyl]fenyl]-3H-1,2 4-triazol-3-one, | 184177-83-1 | Antibiotika |
| sheprevent | (2S)-2-Cyclohexyl-N-(2-pyrazinylkarbonyl)glycyl-3-methyl-L-valine | 402958-96-7 | Antivirus |
| Entecavir | 6-(benzyloksy)-9-((1S,3R,3S)-4-(benzyloksy)-3-(benzyloksymethyl)-2-methylenecyclopentyl)-N-((4-methoxyphenyl)diphenylmethyl)-9H-purin-2 -amine | 142217-80-9 | Antivirus |
| Famciclovir | 9-(4-Acetoxy-3-acetoxymethylbutyl)-2-amino-6-chloropurine | 97845-60-8 | Antivirus |
| Lusuthrombopag | (E)-3,5-dichloor-4-(3-ethoksy-2-methyl-3-oxoprop-1-enyl)benzoëzuur | 1110767-89-9 | Antivirus |
| Lusuthrombopag | (S)-4-(3-(1-(hexyloxy)ethyl)-2-methoxyphenyl)thiazol-2-amine | 1110767-98-0 | Antivirus |
| Linezolid | Linezolid | 165800-03-3 | Antivirus |
| Pregabalin | 3-Carbamoymethyl-5-methylhexanoic acid | 181289-15-6 | sintraal senuwstelsel |
